The Leader in Nasal Decolonization

Watch the Video!

See how clinically proven Nozin IP Programs can reduce infection, improve patient care and lower costs.

Evidence

Evidence shows that nasal bacteria are a primary component in the spread of infection.

%

30% of population carry staph aureus in the nose

%

80% of wound infections traced to patients' own nasal bacteria DNA

%

44% reduction in ICU infections with universal nasal and skin decolonization

%

Infection reduced by 81% with Nozin 360 added to an existing IP bundle

Nasal Decolonization White Papers

Healthcare professionals are invited to download our FREE white papers on the nasal decolonization landscape.

Emerging Strategies on Achieving Nasal DecolonizationNasal Decolonization's Broadening Application

 

Emerging Strategies on Achieving Nasal Decolonization For Reducing Hospital Acquired Infections
& Nasal Decolonization's Broadening Application: Replacing Contact Precautions

News and Major Published Articles

Baylor SSI Study Published

Perioperative participation of orthopedic patients and surgical staff in a nasal decolonization intervention to reduce Staphylococcus...

View Full Article

IDSA Annual Meeting

Baylor Orthopedic and Spine Hospital at Arlington presented results of a study entitled: Pre- and Post-Operative Participation of Orthopedic Patients...

View Full Article

Nozin Effective in Treating Staph aureus Nasal Carriage

MarketWatch  has published the press article: “Nozin Antiseptic Drug Effective in Treating Staph aureus Nasal Carriage”

View Full Article

Nasal Decolonization and HAI Prevention

New article by Sue Barnes, RN, CIC, the former national program leader for infection prevention at Kaiser Permanente. Click below to view full article.

View Full Article

APIC 2016 Conference

Nina Deatherage, BSN, RN, PHN, CIC, and Infection Control Lead at Marshall Medical Center presented results of eliminating MRSA contact precautions at Marshall.

View Full Article

Reduction of nasal Staphylococcus aureus carriage

The American Journal of Infection Control (AJIC) has in press the article: “Reduction of nasal Staphylococcus aureus carriage in health care professionals by treatment with a nonantibiotic, alcohol-based...

View Full Article

Strength in Numbers

In this article the author, Valerie Dimond, makes a case for stronger cooperation in achieving goals of Antimicrobial Stewardship Programs (ASPs).

View Full Article

MRSA at Marshall Medical Center

Reuters is among a number of news outlets that have run the press article: “Nozin Nasal Drug Reduces Risk and Cost Associated with MRSA at Marshall...

View Full Article

References

1. Mullen A, et al. Perioperative participation of orthopedic patients and surgical staff. AJIC, 2017, Vol 45, Issue 5, 554 - 6.
2. Huang SS et al. Targeted versus universal. N Engl J Med, 2013: 368(24): 2255-65
3. Huang SS et al. Cost Savings of Universal Decolonization to Prevent Intensive Care Unit Infection. ICHE, 2014: 35 (S3): S23-S31.
4. Sanchita, Das, et.al. 2014. Active Surveillance and Decolonization Without Isolation. Open forum infectious diseases 1(2): ofu067.
5. Nasal decolonization and CHG bathing.
6. Steed L, et al. Reduction of nasal Staphylococcus aureus carriage. AJIC 2014: 42(8): 841-846.


Health Professionals:
Request Nozin® samples for your facility.
© 2004-2017 Global Life Technologies Corp. All rights reserved. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease.